Definitive Healthcare Corp Reports Q2 Financial Results for Period Ending June 30 2024
Intellectia.AI2024-08-08
Definitive Healthcare Corp. Reports Q2 Financial Results for Period Ending June 30, 2024
Overview
Definitive Healthcare Corp. has reported its financial results for the second quarter ended June 30, 2024.
Key Financial Metrics
The following table summarizes key financial metrics:
| Metric | Q2 2023 | Q2 2024 | YoY Change | Wall Street Consensus (Q2 2024) | Performance vs. Consensus |
|---|---|---|---|---|---|
| Total Revenue | $61.7M | $64.5M | +4.5% | $63.16M | Exceeded |
| Earnings Per Share (EPS) | $(0.08) | $(2.72) | N/A | $0.09 | Below |
Interpretation : Definitive Healthcare Corp. reported a revenue of $64.5M for Q2 2024, slightly exceeding the Wall Street consensus estimate of $63.16M. However, the company posted an EPS of $(2.72), significantly below the projected $0.09 due to a goodwill impairment charge.
Dividends and Share Repurchase Program
During the quarter, Definitive Healthcare Corp. repurchased 1,258,565 shares of its Class A Common Stock for $7.0 million under a stock repurchase program authorized by the company’s Board of Directors. No dividends were announced.
Stock Price Movement
The stock price of Definitive Healthcare Corp. declined by 4.05% following the earnings release.
This article provides a concise summary of the recently reported financial results for Definitive Healthcare Corp., highlighting key financial metrics, shareholder activity, and the resulting stock price movement.
Share